MAPK1 and cancer: Across a series of cancer cell lines, including MDA-MB-468, CuE (100–200 nM) induced G2/M phase arrest and apoptosis; these cellular outcomes were associated with reduced p-STAT3, p-AKT, and p-ERK with increased levels of p-JNK [101].